Hypnogen

Zolpidem, the active ingredient in Hypnogen, is a non‑benzodiazepine hypnotic presented as an oral tablet for oral use. It is indicated for the short‑term treatment of insomnia in adult patients who have difficulty initiating or maintaining sleep. The medication acts on the central nervous system to promote sleep without the dependence profile of traditional benzodiazepines.

GNH USA supplies Hypnogen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is manufactured under strict quality controls.

Zolpidem is a non‑benzodiazepine hypnotic used to manage sleep disorders, primarily insomnia.

- Insomnia (difficulty falling asleep): facilitates faster sleep onset in adults. - Insomnia (difficulty maintaining sleep): helps reduce nocturnal awakenings and improve sleep continuity. - Insomnia (early morning awakening): may extend total sleep time by decreasing early awakenings.

Zolpidem may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects: - Drowsiness or excessive daytime sleepiness - Dizziness or light‑headedness - Headache - Nausea or gastrointestinal discomfort - Dry mouth - Amnesia or memory lapses

Serious or Rare Side Effects: - Complex sleep behaviours (sleepwalking, sleep‑driving) - Allergic reactions (rash, swelling, anaphylaxis) - Depression or suicidal thoughts - Respiratory depression, especially with other depressants - Severe hypotension or cardiovascular events

When prescribing zolpidem, clinicians should consider several safety precautions to minimize risk.

- Assess sleep duration: limit use to short‑term periods (typically ≤4 weeks). - Review concomitant CNS depressants: avoid combined use with alcohol or other sedatives. - Evaluate hepatic function: dose may need adjustment in severe liver impairment. - Monitor for complex sleep behaviors: educate patients about activities performed while not fully awake. - Pregnancy and lactation: weigh benefits against potential risks; use only if clearly needed. - Store at ambient temperature: keep tablets in original container, protect from moisture and heat.

Zolpidem can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) - Alcohol or other central nervous system depressants - Opioids or barbiturates

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine) - Selective serotonin reuptake inhibitors (SSRIs) and other antidepressants - Antihistamines and over‑the‑counter sleep aids